UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics

Breast cancer research : BCR, 2010-01, Vol.12 (3), p.R42-R42, Article R42

2010

Volltextzugriff (PDF)

Identification of Subtypes in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome

Journal of clinical oncology, 2010-04, Vol.28 (11), p.1813-1820

2010

Volltextzugriff (PDF)

A Breast Cancer Candidate Locus at 6q Narrowed to 6q15-q21

Genes, 2024-02, Vol.15 (2), p.218

2024

Volltextzugriff (PDF)

The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability

Genes, 2019-11, Vol.10 (11), p.882

2019

Volltextzugriff (PDF)

The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients

BMC cancer, 2012-12, Vol.12 (1), p.621-621

2012

Volltextzugriff (PDF)

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression

Breast cancer research : BCR, 2011-09, Vol.13 (5), p.R95-R95

2011

Volltextzugriff (PDF)

Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors

International journal of cancer, 2006-09, Vol.119 (5), p.1052-1060

2006

Volltextzugriff (PDF)

The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714predict adverse outcome for breast cancer patients

BMC cancer, 2012-12, Vol.12 (1), Article 621

2012

Volltextzugriff (PDF)

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative

Cancer discovery, 2021-11, Vol.11 (11), p.2796-2811

2021

Volltextzugriff (PDF)

Abstract 3709: miR-21-3p: A potential oncomir in breast cancer

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3709-3709

2020

Volltextzugriff (PDF)

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer

Nature genetics, 2007-07, Vol.39 (7), p.865-869

2007

Volltextzugriff (PDF)

High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer

Breast cancer research : BCR, 2010-01, Vol.12 (3), p.R25-R25, Article R25

2010

Volltextzugriff (PDF)

The Retinoblastoma Gene Undergoes Rearrangements in BRCA1-Deficient Basal-like Breast Cancer

Cancer research (Chicago, Ill.), 2012-08, Vol.72 (16), p.4028-4036

2012

Volltextzugriff (PDF)

Counsellee’s experience of cancer genetic counselling with pedigrees that automatically incorporate genealogical and cancer database information

Journal of community genetics, 2016-07, Vol.7 (3), p.229-235

2016

Volltextzugriff (PDF)

Deletions on Chromosome 4 in Sporadic and BRCA Mutated Tumors and Association with Pathological Variables

Anticancer research, 2004-09, Vol.24 (5A), p.2681-2687

2004

Volltextzugriff (PDF)

Abstract 3461: Expression levels of TOX3 and the risk allele of the associated SNP rs3803662 predict adverse outcome for breast cancer patients

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.3461-3461

2013

Volltextzugriff (PDF)

Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families

Breast cancer research : BCR, 2010-01, Vol.12 (4), p.R50-R50, Article R50

2010

Volltextzugriff (PDF)

The use of genealogy databases for risk assessment in genetic health service: a systematic review

Journal of community genetics, 2013-01, Vol.4 (1), p.1-7

2013

Volltextzugriff (PDF)

Genomic and phenotypic analysis of BRCA2mutated breast cancers reveals co-occurring changes linked to progression

Breast cancer research : BCR, 2011-09, Vol.13 (5), Article R95

2011

Volltextzugriff (PDF)

Abstract 1855: Genome-wide search for linkage in Icelandic high-risk breast cancer families

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1855-1855

2010

Volltextzugriff (PDF)

A non-synonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

Cancer epidemiology, biomarkers & prevention, 2012-06, Vol.21 (8), p.1362-1370

2012

Volltextzugriff (PDF)

Evidence against PALB2 involvement in Icelandic breast cancer susceptibility

Journal of negative results in biomedicine, 2008-07, Vol.7 (1), p.5-5, Article 5

2008

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

7 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics

Identification of Subtypes in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome

A Breast Cancer Candidate Locus at 6q Narrowed to 6q15-q21

The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability

The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression

Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors

The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714predict adverse outcome for breast cancer patients

Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative

Abstract 3709: miR-21-3p: A potential oncomir in breast cancer

Parental origin of sequence variants associated with complex diseases

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer

High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer

The Retinoblastoma Gene Undergoes Rearrangements in BRCA1-Deficient Basal-like Breast Cancer

Counsellee’s experience of cancer genetic counselling with pedigrees that automatically incorporate genealogical and cancer database information

Deletions on Chromosome 4 in Sporadic and BRCA Mutated Tumors and Association with Pathological Variables

Abstract 3461: Expression levels of TOX3 and the risk allele of the associated SNP rs3803662 predict adverse outcome for breast cancer patients

Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families

The use of genealogy databases for risk assessment in genetic health service: a systematic review

Genomic and phenotypic analysis of BRCA2mutated breast cancers reveals co-occurring changes linked to progression

Abstract 1855: Genome-wide search for linkage in Icelandic high-risk breast cancer families

A non-synonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

Evidence against PALB2 involvement in Icelandic breast cancer susceptibility

Suchergebnisse filtern